Updated results from a trial with belzutifan for people with advanced kidney cancer
Kidney cancers frequently have mutations in the von Hippel-Lindau (VHL) gene, [...]
Kidney cancers frequently have mutations in the von Hippel-Lindau (VHL) gene, [...]
Kidney cancers frequently have mutations in a gene called the [...]
In a small phase 2 study presented at the virtual [...]
This article summarises the key breakthroughs in the treatment of [...]
During this interview, Dr Rana McKay from the University of [...]
One of the major breakthroughs this year the hypoxia-inducible factor [...]
Von Hippel-Lindau (VHL) disease–associated renal cell carcinoma (RCC) has always [...]
At the European Society of Medical Oncology (ESMO) Virtual Congress [...]
Results from a phase II international trial led by researchers [...]
In this interview with Practice Update, Dr Eric Jonasch from [...]